Xiaolong Liao
Publications by Year
Research Areas
CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Virus-based gene therapy research, Immune Cell Function and Interaction, Immunotherapy and Immune Responses
Most-Cited Works
- → 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies(2019)185 cited
- → CD33-Specific Chimeric Antigen Receptor T Cells with Different Co-Stimulators Showed Potent Anti-Leukemia Efficacy and Different Phenotype(2018)95 cited
- → HI44a, an anti-CD44 monoclonal antibody, induces differentiation and apoptosis of human acute myeloid leukemia cells(2004)49 cited
- → Induced CD20 Expression on B-Cell Malignant Cells Heightened the Cytotoxic Activity of Chimeric Antigen Receptor Engineered T Cells(2018)27 cited
- → Identification of a Novel Isoform of iASPP and its Interaction with p53(2007)19 cited
- → Chimeric antigen receptor-engineered T cells and its clinical application(2016)1 cited
- → Dashijian Reservoir spillway physical shape optimisation design using model experiment(2023)1 cited
- Human extracellular domain of 4-1BBL enhances the PBL-based antitumor effect of anti-CD3/anti-Pgp diabody in vitro and vivo(2010)
- → HIM1 and HIM4, two monoclonal antibodies potentially useful for autologous bone marrow transplantation in chronic myelogenous leukemia(1990)
- → Incorporation of 4-1BB Endowed the Potent CD33 Specific Chimeric Antigen Receptor T Cells with Anti-Exhaustion Capacity and Increased Central Memory Compartment(2017)